BRAF and neoplasm: In more detail, tumor gDNA from patient 3 had a VAF of 0.5 using a patient-specific fusion assay, indicating a monoallelic BRAF duplication event in a tumor biopsy sample with 100% purity, while the corresponding screening BRAF duplication assay had a CNV = 3.04.